Highlights Evolutionary Genomics, Inc.

Equities

FNAM

US30051F1012

Market Closed - OTC Markets Other stock markets 20:26:12 18/07/2023 BST			5-day change	1st Jan Change
0.45 ^USD	-25.00%		-.--%	-.--%

2023	Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2023	Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	09/03/23	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/10/22	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	08/08/22	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22/03/22	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	01/11/21	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	06/08/21	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/05/21	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	31/03/21	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	13/11/20	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	19/08/20	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	12/05/20	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	30/03/20	CI
Evolutionary Genomics, Inc. and Eg I, Llc Reports Earnings Results for the Third Quarter Ended September 30, 2019	17/10/19	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	12/08/19	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	15/05/19	CI
Evolutionary Genomics, Inc. and Eg I, Llc Reports Earnings Results for the Full Year Ended December 31, 2018	01/04/19	CI
Evolutionary Genomics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2018	14/11/18	CI
Evolutionary Genomics, Inc. (EG) and EG I, LLC completed the acquisition of Fona, Inc. from Desfaire, Inc. and other shareholders in a reverse merger transaction.	19/10/15	CI
Evolutionary Genomics, Inc. (EG) and EG I, LLC entered into an agreement and plan of merger to acquire Fona, Inc. from Desfaire, Inc. and other shareholders in a reverse merger transaction.	12/06/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Evolutionary Genomics, Inc.

Equities

FNAM

US30051F1012

Highlights

Filters